Target intelligence / Profile preview

IQ calmodulin-binding motif-containing protein 1 (IQCB1)

Target
IQCB1
Molecular classification
Other (calmodulin-binding protein), Ciliary protein
01

Overview

IQ calmodulin-binding motif-containing protein 1 (IQCB1), also called nephrocystin-5 (NPHP5), is a ubiquitously expressed ciliary protein encoded by the IQCB1 gene located on human chromosome 3q13.33[1][2]. It contains IQ domains for calmodulin binding and is essential for ciliogenesis, particularly in the development and maintenance of structures such as photoreceptor outer segments in the retina. Mutations in IQCB1 are causative for rare autosomal recessive ciliopathies, especially Senior-Løken syndrome, which combines nephronophthisis (a chronic kidney disorder) with early-onset retinal degeneration (Leber congenital amaurosis). Pathogenic IQCB1 variants disrupt photoreceptor structure and renal function. There are currently no therapies that target IQCB1 directly; its value is principally in genetic diagnosis and understanding the pathogenesis of cilia-related diseases[2][4][8].

Other names
NPHP5KIAA0036Nephrocystin-5SLSN5PIQOK/SW-cl.85p53 and DNA damage-regulated IQ motif proteinnephrocystin 5
02

Mechanism of action

Not applicable (no approved drugs targeting IQCB1)

03

Biological functions

CiliogenesisCalmodulin bindingProtein-protein interactionPhotoreceptor outer segment formationCytosolic ciliogenesis
04

Disease associations

CiliopathiesLeber congenital amaurosis (early-onset severe retinal degeneration)Senior-Løken syndrome (retinal-renal ciliopathy)Nephronophthisis (kidney disease)
05

Biomarkers

Mutation detection for diagnosis of Senior-Løken syndrome and Leber congenital amaurosis (NPHP5/LCA genetic testing)

Beyond the preview

Go deeper on IQ calmodulin-binding motif-containing protein 1 (IQCB1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on IQ calmodulin-binding motif-containing protein 1 (IQCB1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call